Impact of TECAR in Treatment of Rectus Diastasis
Impact of TECAR Therapy in Treatment of Post-natal Rectus Diastasis
1 other identifier
interventional
30
1 country
1
Brief Summary
The study aim to evaluate the impact of TECAR treatment on rectus diastasis in postnatal women
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2022
CompletedFirst Posted
Study publicly available on registry
March 18, 2022
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedJanuary 12, 2023
January 1, 2023
3 months
March 10, 2022
January 11, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
rectus abdominis cross section area
1 cycle (42 days)
fat thickness
1 cycle (42 days)
intra-recti distance
1 cycle (42 days)
Study Arms (2)
TECAR application
EXPERIMENTALselected abdominal exercises program
ACTIVE COMPARATORInterventions
Radiofrequency (RF) is the emission of high frequency waves via an applicator. The transfer of electromagnetic energy stimulates targeted tissues. RF can be used in two ways: capacitive or resistive The capacitive mode (CET) concentrates the energy to target soft tissues containing electrolytes: muscles, vascular or lymphatic tissues. The resistive mode (RET) targets denser tissues containing more fat and fiber (such as bones, ligaments and tendons). High frequency waves penetrate deep into tissues and increase both exchanges and temperature and a recent study has demonstrated the effects of RF on the skin microcirculation and the intramuscular blood flow
Eligibility Criteria
You may qualify if:
- postnatal females suffering from diastasis recti more than 2.5 cm with bulged abdomen,
- Their age ranged from 25 - 35 years.
- Their body mass index (BMI) ranged from 25-35 kg/m2.
- All women delivered normally
You may not qualify if:
- Any participant was excluded if she had any disease that interferes with exercises (asthma), any skin disease or sensitivity that interferes with the application, any chest disease or cardiac disease or women had abdominal surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Kafrelshiesk university hospital
Tanta, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Eman A Elhosary, Professor
Assistant professor of physical therapy, Physical therapy faculty, Kafrelsheikh University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of physical therapy, Basic Sciences department, Physical therapy faculty, Cairo University
Study Record Dates
First Submitted
March 10, 2022
First Posted
March 18, 2022
Study Start
June 1, 2022
Primary Completion
August 31, 2022
Study Completion
September 30, 2022
Last Updated
January 12, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share